Clinical Trial Update: GI Permeability Change in Response to Aquamin® [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of Aquamin on gastrointestinal permeability in Ulcerative Colitis patients, Irritable Bowel Syndrome with diarrhea patients,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea
• Ulcerative Colitis

Drugs mentioned

• Aquamin

Snippet

Sponsor: James Varani | Conditions: Ulcerative Colitis, Healthy | Phase 2 | Status: COMPLETED